Monoplegia
Showing 1 - 25 of 108
Cerebral Palsy, Brain Diseases Trial in Hérouville Saint-Clair, Le Havre (Virtual reality rehabilitation)
Recruiting
- Cerebral Palsy
- Brain Diseases
- Virtual reality rehabilitation
-
Hérouville Saint-Clair, Normandy, France
- +2 more
Oct 25, 2022
Aortic Dissection Trial in United States (Valiant Thoracic Stent Graft with the Captivia Delivery System)
Completed
- Aortic Dissection
- Valiant Thoracic Stent Graft with the Captivia Delivery System
-
Los Angeles, California
- +16 more
Oct 27, 2021
Spasticity Trial in Czechia, United States (Phase 2; Low Dose MYOBLOC, Phase 2; High Dose MYOBLOC, Phase 2; Placebo)
Recruiting
- Spasticity
- Phase 2; Low Dose MYOBLOC
- +4 more
-
Downey, California
- +8 more
Mar 4, 2022
Spasticity, Cerebrovascular Accident, Multiple Sclerosis Trial in Czechia, United States (Phase 2; Low Dose MYOBLOC, Phase 2;
Recruiting
- Spasticity
- +5 more
- Phase 2; Low Dose MYOBLOC
- +4 more
-
Downey, California
- +8 more
Mar 4, 2022
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Migraine Trial in Iruma (TEV-48125, TEV-48125 or , Placebo)
Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)
Completed
- Ovarian Neoplasms
- Ovarian Cancer
-
Chandler, Arizona
- +54 more
Sep 24, 2021
Prostate Cancer Trial in Japan (Enzalutamide, Flutamide, Androgen deprivation therapy)
Soft Tissue Sarcoma Trial in Worldwide (Eribulin mesylate 1.4 mg/m^2 intravenous, Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or
Completed
- Soft Tissue Sarcoma
- Eribulin mesylate 1.4 mg/m^2 intravenous
- Dacarbazine of 850 mg/m^2, or 1,000 mg/m^2, or 1,200 mg/m^2 IV
-
Tucson, Arizona
- +118 more
Jul 14, 2020
Advanced Metastatic Breast Cancer Trial in Germany (ribociclib, letrozole, goserelin)
Completed
- Advanced Metastatic Breast Cancer
- ribociclib
- +2 more
-
Muenchen, Bayern, Germany
- +83 more
Oct 7, 2021
Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)
Terminated
- Cardiovascular Disease
- Dalcetrapib
- Placebo
-
Los Angeles, California
- +109 more
Mar 20, 2020
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Trial in Worldwide (brexucabtagene autoleucel, Cyclophosphamide,
Active, not recruiting
- Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
- brexucabtagene autoleucel
- +2 more
-
La Jolla, California
- +32 more
Mar 16, 2022
Type 2 Diabetes Trial (Sitagliptin, Placebo)
Refractory Metastatic Gastric Cancer Trial in Worldwide (TAS-102, Placebo)
Completed
- Refractory Metastatic Gastric Cancer
- TAS-102
- Placebo
-
Gilbert, Arizona
- +138 more
Aug 19, 2021
Advanced Solid Tumors, Advanced B-cell NHL Trial in Worldwide (Urelumab, Nivolumab)
Terminated
- Advanced Solid Tumors
- Advanced B-cell NHL
- Urelumab
- Nivolumab
-
Palo Alto, California
- +16 more
Sep 10, 2020
Cancer, Breast Cancer Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)
Completed
- Cancer
- Breast Cancer
- Ixabepilone + Capecitabine
- Capecitabine
-
Tucson, Arizona
- +188 more
Oct 6, 2020
Prevention & Control Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin )
Completed
- Prevention & Control
- Rivaroxaban (Xarelto, BAY59-7939)
- +5 more
-
Birmingham, Alabama
- +564 more
Nov 3, 2022
Small Cell Lung Carcinoma Trial in Worldwide (Ipilimumab, Placebo matching Ipilimumab, Etoposide)
Completed
- Small Cell Lung Carcinoma
- Ipilimumab
- +4 more
-
Hot Springs, Arkansas
- +224 more
Jul 6, 2020
High Grade Glioma Trial in Worldwide (Bevacizumab, Radiotherapy, Temozolomide (TMZ))
Completed
- High Grade Glioma
- Bevacizumab
- +2 more
-
Westmead, New South Wales, Australia
- +52 more
Jul 23, 2020
Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)
Completed
- Advanced Renal Cell Carcinoma
- (no location specified)
Jun 10, 2020
